Science|Business Database: Coronavirus Funding Opportunities

This call aims to strengthen the evidence base to better prevent and control coronavirus (COVID-19) epidemics and to increase research and response capacity.

Contributions must improve treatment, diagnosis or the public health response to the COVID-19 epidemic.

UK researchers are invited to study cardiovascular complications in COVID-19 infection, their prevention, short and long-term impact, and why patients with heart and circulatory diseases are at greater risk of adverse outcomes.

Grants for developing mathematical models, biomedical/nano sensors, algorithms, security techniques and other technologies in preparation for future pandemics. Applications are reviewed on a rolling basis. 

Cardiovascular-focused applications that will contribute to understanding the cardiovascular and cerebrovascular pathogenesis, diagnosis, prevention, clinical manifestations, clinical management (including critical care management) and social beha

€7M are available for collaborative research projects lasting 12 months that can rapidly acquire knowledge about potential clinical and public health measures to be used immediately to improve patient health.

One postdoctoral position is available at the Laboratory of Innate Immunity and Microbial Pathogenesis, São Paulo, Brazil, for research into the role of inflammatory cytokines in COVID-19.

Projects must advance the understanding of COVID-19 and the development of vaccines, therapeutics, and diagnostics. Multidisciplinary collaborations and use of international research networks are encouraged.

Research teams from Poland and Switzerland are invited to carry out joint high-quality research projects on COVID-19.

Proposals may address the biology of respiratory viruses, epidemiological approaches to them, development of novel therapeutics and vaccines, deciding host factors and individual, regional, or social factors affecting community spread of COVID-19.

Projects lasting up to 9 months should collect data on the clinical course and outcome of COVID-19 in vulnerable populations, investigate long-term consequences of COVID-19 in patients, or test the safety and effectiveness of remdesivir in treatin

The research should determine how susceptible cystic fibrosis (CF) cells are to COVID-19, identify and evaluate responses to the virus in people with CF, and understand how commonly prescribed medications used in CF may alter responses to the viru

Competitive revisions to active grants in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeut

Competitive revisions to active grants in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeut

NIAID announces that a number of existing calls will particularly welcome research objectives related to pathogenicity, transmission, medical countermeasures, pre-clinical testing of vaccines and therapeutics.